Issue: January/February 2017, Posted Date: 2/16/2017

Pfizer CentreOne Expands Fill-Finish Services


Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, recently announced that it has expanded its fill-finish services to its Kalamazoo, MI, site.  Along with vial-filling of small molecules and biologics, the facility also provides vial-filling of sterile suspensions, expanding Pfizer CentreOne’s service portfolio.  


“Kalamazoo was the obvious choice for expansion of our fill-finish services,” said Peter Stevenson, Pfizer CentreOne’s Vice President and General Manager. “Our Kalamazoo colleagues have been doing contract manufacturing for over 40 years on the API side – it’s part of the culture; and this is also one of Pfizer’s premier sterile-injectables sites. It’s a natural fit.”  With more than 65 years of experience in injectables fill-finish, Kalamazoo currently supplies drugs to more than 100 countries around the globe. 


Kalamazoo Vial-Filling Services

Services at the Kalamazoo site encompass:


-Small molecules and biologics

-Sterile suspensions

-Potent and controlled substances

-Aqueous and oil-based formulations


-Vials 1-100mL; bulk formulation <1-1600 liters


Technical Transfer

The Kalamazoo facility has dedicated, onsite technical, manufacturing science, regulatory affairs and quality teams. Over the past 5 years, they’ve successfully transferred 37 customer and Pfizer compounds into the facility. Among Kalamazoo’s extensive scientific resources are experts in API processes who know how to solve complex issues with active ingredients; and a team of commodities experts who trouble-shoot problems with stoppers, glass and excipients. 


“Our biopharma partners will be in good hands at Kalamazoo,” stated Stevenson, “with a dedicated Pfizer CentreOne team by their side who deeply understand their needs, who can leverage a world of top-flight resources at the site on their behalf.”


Said Bob Betzig, Kalamazoo site head, who oversees all operations on the Kalamazoo campus, “We’re thrilled to expand our contract manufacturing services to include sterile injectables. We value our contract manufacturing partners and pride ourselves on producing difficult-to-make injectables. Our team is ready and waiting.”


About Pfizer CentreOne

A global contract manufacturer embedded within Pfizer, Pfizer CentreOne focuses on API synthesis, sterile injectables fill-finish and highly potent solids. Formed by the union of Pfizer CentreSource, a global leader in specialty APIs, and Hospira One 2 One, one of the world’s premier sterile-injectables CMOs, Pfizer CentreOne has more than 40 years’ experience manufacturing complex compounds for biopharmaceutical partners. For more information, visit


Questions?  Please contact Kristen Berg, Communications Manager, Pfizer CentreOne,, 224-212-5466.

This record has been viewed 1004 times.


Click here to see the showcases

BIO Investor Forum
October 17-18, 2017
The Westin St. Francis, San Francisco, CA US
Partnership Opportunities in Drug Delivery (PODD)
October 19-20
Boston, MA

CPhI Worldwide
October 24-26
Frankfurt, Germany

Universe of Prefilled Syringes & Injection Devices Europe
November 7-8
Vienna, Austria

November 12-17
San Diego, CA

Pre-Filled Syringes Europe
January 17-18, 2018
Copthorne Tara Hotel, London UK

Drug Delivery Partnerships
January 22-24 Palm Beach, FL

3rd Annual Drug Development Networking Summit
March 8, 2018  Hilton Hotel Parsippany NJ
PDA Annual Meeting
March 19-21 Orlando, FL
CPhI North America
April 24-26 Philadelphia, PA 
April 17-19 New York City
RDD (Respiratory Drug Delivery)
April 22-26 Tucson, AZ
BIO 2018
June 4-7 Boston, MA
Controlled Release Society Meeting
July 23-25 New York City
Universe of Prefilled Syringes & Injection Devices
October 8-9 Orlando, FL

Copyright © 2017  Drug Development & Delivery All Rights Reserved. Privacy Policy / Terms and Conditions